Search

everythinglearnresearchcommunity

for

Search:↓

Anti-TNF-α therapy may increase the risk of developing alopecia areata, especially in those with a history of autoimmune disease.

Acitretin significantly reduced inflammatory attacks in a woman with Naevus Comedonicus Syndrome but caused side effects.

IFN-γ and IL-2 are important for T cell activation in hair loss in mice.

IVIG therapy significantly improved symptoms in a patient with APS-2 and SPS.

The treatment was not recommended due to limited effectiveness and significant side effects.

Modern treatments can effectively regrow hair and improve life for people with alopecia areata.

JAK inhibitors improve hair growth in alopecia areata, especially in patchy types.

The QuantAnts machines can find cancer markers and create CRISPR targets for them.

Major histocompatibility antigens are found in specific skin cells and structures, but not in sweat glands.

LHTric-1 is a specific antibody useful for studying hair and nail formation.

IL-4 and IL-13 might play a role in a type of hair loss similar to alopecia areata.

CDH3-related disease causes worsening eye and hair issues.

Atopic dermatitis needs personalized treatment using various therapies, starting with topical corticosteroids.

Zinc supplements improved symptoms in a Uyghur infant with a rare genetic disorder affecting zinc absorption.

SLE is likely one disease with various symptoms, not multiple distinct diseases.

Adding antihistamines to topical corticosteroid and cryotherapy may improve hair regrowth in alopecia areata patients.

The new aptamer TAGX-0003 shows promise as an effective treatment for hair loss disorder alopecia areata.

Early diagnosis and genetic counseling are crucial for managing adrenoleukodystrophy.

HDPCM treatment healed a baby's congenital skin defect caused by varicella infection.

A group has developed therapies that show promise for treating cancer and various other conditions.

Alopecia areata may be linked to higher heart disease risk.

Hospitalizations for atopic dermatitis are more due to other health issues now, not the condition itself.

Certain skin proteins can form anchoring structures without the protein AMACO.

Hair regrowth was seen in 83% of children with alopecia, immune system plays a role in the condition, and various treatments showed effectiveness for hair and nail disorders.

Squaric acid dibutylester effectively treats alopecia areata.

Tofacitinib and baricitinib are effective and safe for treating severe alopecia areata, especially in younger people.

Some young Angus cattle had skin problems due to not enough vitamin A, which got better after they were given more vitamin A.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Baricitinib is effective and safe for treating severe alopecia areata.

Tofacitinib works better and is more tolerable for severe alopecia than conventional treatments and DPCP immunotherapy.